Marwick T H, Case C, Siskind V, Woodhouse S P
Department of Cardiology, Princess Alexandra Hospital, Woolloongabba, Australia.
Lancet. 1988 Jul 9;2(8602):66-8. doi: 10.1016/s0140-6736(88)90003-7.
Resuscitation for cardiac arrest was monitored over 4 years to examine the effect on survival of a change in the ventricular fibrillation (VF) protocol to include the routine early use of "high-dose" intravenous or transbronchial adrenaline. A significant reduction in the immediate survival of patients with VF was seen when the protocol was changed (22% after the change, 43% before). Prior predictors of poor response were similar in each group, except for the number of witnessed arrests, delay until cardiopulmonary resuscitation, and occurrence of endotracheal intubation, but multiple logistic regression showed the use of adrenaline to be an independent predictor of outcome. Early high-dose adrenaline was associated with a reduction in immediate survival in patients with persistent VF.
对心脏骤停的复苏情况进行了4年的监测,以研究将室颤(VF)方案变更为包括常规早期使用“大剂量”静脉注射或经支气管肾上腺素后对生存率的影响。当方案变更后,VF患者的即刻生存率显著降低(变更后为22%,变更前为43%)。除了目击心脏骤停的次数、直到进行心肺复苏的延迟时间以及气管插管的发生情况外,每组中反应不佳的先前预测因素相似,但多因素逻辑回归显示肾上腺素的使用是结局的独立预测因素。早期大剂量肾上腺素与持续性VF患者的即刻生存率降低有关。